Alyssa Lucchesi

Ms. Alyssa Lucchesi

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2026 in Marine Drugs
Verified
Journal Article
Open access
PDF file
AAAla Alzubi
Ala Alzubi
ALAlyssa Lucchesi
Alyssa Lucchesi
JBJessie Burns
Jessie Burns
CCClara Cho
Clara Cho
DMDavid Ma
David Ma
JMJennifer Monk
Jennifer Monk
Obesity is a complex metabolic disorder defined by a body mass index greater than 30 kg/m2, excess adipose tissue accumulation, chronic low-grade inflammation and metabolic dysfunction, leading to increased susceptibility to other chronic conditions. Evidence from both mechanistic pre-clinical studies and human clinical trial suggests a role for long-chain (LC) n-3 polyunsaturated fatty acids (PUFAs), namely eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), to modulate obesity-associated outcomes and attenuate the production of inflammatory mediators, namely adipokines from adipose tissue and myokines from skeletal muscle, that can mitigate inflammation-associated metabolic dysfunction. Therefore, this narrative review synthesizes evidence and mechanistic insights on the role(s) of n-3 PUFA in regulating obesity-associated changes in adipose tissue and skeletal muscle inflammation and immune cell trafficking and metabolic outcomes.